Reimbursement Systems for Wound Care Products in Selected European Countries

About

New Report: Reimbursement Systems for Wound Care Products in Selected European Countries

We’re excited to introduce our latest report, providing key insights into the complex landscape of reimbursement systems across Europe. This first edition covers 13 European countries, highlighting key differences in policies, healthcare settings, and regional frameworks.

Countries covered: 🇧🇪 Belgium | 🇧🇦 Bosnia & Herzegovina | 🇫🇮 Finland | 🇬🇷 Greece | 🇭🇺 Hungary | 🇮🇹 Italy | 🇳🇱 Netherlands | 🇳🇴 Norway | 🇵🇹 Portugal | 🇪🇸 Spain | 🇨🇭 Switzerland | 🇹🇷 Turkey | 🇬🇧 United Kingdom

Who is this for?

This report is an essential resource for companies navigating the European wound care market, supporting strategic decision-making and market entry.

Get your copy today!
Price: €350

Free for members of EWMA Innovation Alliance → Join here https://lnkd.in/d7F5mT-H

Instant download available after purchase: https://lnkd.in/dmHtRVJv

Stay ahead with the insights you need to succeed!

Image 1: Chronic wound infection#1, CLSM, 63x, S. aureus

Image 2: Chronic wound infection#2, CLSM, 63x, S. aureus

Image 3: Chronic wound infection#3, CLSM, 63x, S. aureus

Image 3: Chronic wound infection#4, CLSM, 63x, P. aeruginosa

Figure 1: Schematic drawing of a chronic wound with different species of bacteria heterogeneously distributed in various sizes of biofilms and as single cells from the top to the deeper layers of the wound.
Four confocal microscopy images from patients with a chronic leg wound. Images show biofilms in different sizes with scattered single cells. Bacteria were stained with a universal 16S PNA-FISH probe (red), and eukaryotic cells were counter-stained with DAPI (blue).

Figure 2: List of current assumptions regarding biofilms in wounds.